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Abstract
Background: To investigate if initial blood pressure (BP) on admission is associated with stroke severity and
predictive of admission costs and one-year-outcome in acute ischemic (IS) and hemorrhagic stroke (HS).
Methods: This is a single-center retrospective cohort study. Stroke patients admitted within 3 days after onset
between January 1st and December 31st in 2009 were recruited. The initial BP on admission was subdivided into
high (systolic BP ≥ 211 mmHg or diastolic BP ≥ 111 mmHg), medium (systolic BP 111–210 mmHg or diastolic BP
71–110 mmHg), and low (systolic BP ≤ 110 mmHg or diastolic BP ≤ 70 mmHg) groups and further subgrouped with
25 mmHg difference in systole and 10 mmHg difference in diastole for the correlation analysis with demographics,
admission cost and one-year modified Rankin scale (mRS).
Results: In 1173 IS patients (mean age: 67.8 ± 12.8 years old, 61.4 % male), low diastolic BP group had higher frequency
of heart disease (p =0.001), dehydration (p =0.03) and lower hemoglobin level (p <0.001). The extremely high and low
systolic BP subgroups had worse National Institutes of Health Stroke Scale (NIHSS) score (p =0.03), higher admission cost
(p <0.001), and worse one-year mRS (p =0.03), while extremely high and low diastolic BP subgroups had higher
admission cost (p <0.01). In 282 HS patients (mean age: 62.4 ± 15.4 years old, 60.6 % male), both low systolic and
diastolic BP groups had lower hemoglobin level (systole: p =0.05; diastole: p <0.001). The extremely high and low
BP subgroups had worse NIHSS score (p =0.01 and p <0.001, respectively), worse one-year mRS (p =0.002 and p =0.001,
respectively), and higher admission cost (diastole: p <0.002).
Conclusions: Stroke patients with extremely high and low BP on admission have not only worse stroke severity but
also higher admission cost and/or worse one-year outcome. In those patients with low BP, low admission hemoglobin
might be a contributing factor.
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Background
Cerebrovascular disease (CVD) is an important global
socioeconomic issue due to high disease prevalence,
high morbidity, and aging populations worldwide. The
direct cost of stroke care is related to the intensity of
hospital treatment, in-hospital complication, cardiac
disease, stroke severity, and related disabilities, etc. [1, 2].
More and more studies have focused on the cost of
stroke care with the purpose to achieve better control
of health care expenditure. In Taiwan, over 99 % of the
population and nearly all the hospitals are compulsorily
enrolled in the National Health Insurance (NHI) sys-
tem. There is a need to determine the potentially modi-
fiable patient factors that are associated with increased
medical costs, which may help to redirect resources to
take care of other patients.
Several factors have been proposed to predict the out-
come and costs of acute stroke. Blood pressure (BP) is a
common outcome predictor in acute ischemic (IS) and
hemorrhagic stroke (HS), and elevated initial BP has
been reported to be associated with poor short-term and
long-term outcomes in acute stroke [3]. Previous studies
have found J- or U-shaped correlations between initial
BP and outcome in stroke patients [3]. In IS, high BP on
admission increases the frequency of early neurological
deterioration and predicts unfavorable 90-day outcomes
[4]. The cutoff values of high BP in predicting poor out-
come or mortality were assumed to be 180–220 mmHg
in systolic BP and 120 mmHg in diastolic BP [3, 5]. In
HS, high BP during admission increases the risk of
hematoma extension and predicts poor clinical outcome
and mortality [3, 6]. Previous study noted a threshold of
systolic BP over 170–200 mmHg may predict hematoma
expansion and neurological deterioration [7]. Low BP
during admission has been less extensively studied but is
reported to be predictive of poor outcome [5]. Cardio-
vascular complications could be one factor leading to
poor outcome in HS patients with low BP [8–10]. Some
stroke-related comorbidities such as physical inactivity,
health-care associated infection, and cardiovascular cost
may have financial impacts on these patients [11–13].
The other possible reason why extremely low and high
BP causes poor outcome needs further investigation, and
the correlation between initial BP and admission medical
cost has not been addressed. The aim of our study was
to assess the correlation of initial BP with admission cost
and one-year stroke outcome and study the potentially
associated factors in both IS and HS.
Methods
Patient enrollment and data collection
Patient data were prospectively recorded and retrospect-
ively analyzed from the Stroke Registry of the Chang
Gung Healthcare System (SRICHS). The Human Studies
Institutional Review Board in Chang Gung Memorial
Hospital at Linkou approved this study. SRICHS is a ma-
ture electronic chart-based stroke registry system set up
on March, 2007 [14]. The clinical information of patients
with the diagnosis of acute IS and HS (ICD9 430–437)
was automatically enrolled into this registry and was
anonymized and de-identified prior to analysis. Laboratory
and imaging reports were auto-downloaded from the hos-
pital information system. Clinical data were collected by
the primary care staff and further proofread by the task
force to ensure accuracy.
All acute stroke patients registered in the SRICHS be-
tween January 1st and December 31st in 2009 were re-
cruited for this study if they were admitted within 3 days
after symptom onset in Chang Gung Memorial Hospital,
Linkou Medical Center. All patients received brain com-
puted tomographic (CT) scans and/or magnetic resonance
imaging (MRI) scans to confirm the clinical diagnosis and
were classified into IS and HS groups. Patients were ex-
cluded if (1) the time of stroke onset was uncertain; (2)
intravascular intervention was carried out during admis-
sion; (3) subarachnoid hemorrhages due to aneurysm, ar-
teriovenous malformation, and other vascular anomalies
were diagnosed; (4) admission costs were more than
$33,333 US dollars (equal to 100,000 New Taiwan dollars; 1
US dollar = 30 New Taiwan dollars). We excluded the pa-
tients with exceptionally high costs because most of them
were related to social problems (such as prolonged hospital
stay due to lack of family support or under lawsuit) and
were not associated with the stroke or stroke care treat-
ment per se. The eligible patients were classified into
high, medium, and low systolic BP groups (≥ 211, 111–
210, ≤ 110 mmHg, respectively) and also diastolic BP
groups (≥ 111 mmHg, 71–110 mmHg, ≤ 70 mmHg, re-
spectively) according to the initial BP on admission.
Initial BP was defined as systolic BP and diastolic BP
on admission which was examined by nurses after bed
rest for 5 min. The extremely high BP was defined when
systolic BP ≥ 211 mmHg or diastolic BP ≥ 111 mmHg due
to increased risk of neurological deterioration, mortality,
or disability in these patients [3, 5, 7]. The extremely low
BP was defined as systolic BP ≤ 110 mmHg or diastolic
BP ≤ 70 mmHg based on the increased risk of cardio-
vascular complications in such patients [8, 9]. For cor-
relation analysis with admission cost and one-year
outcome, BP was further subdivided into systolic BP ≤ 110,
111–135, 136–160, 161–185, 186–210, and ≥ 211 mmHg
subgroups and diastolic BP ≤ 70, 71–80, 81–90, 91–100,
101–110, and ≥ 111 mmHg subgroups.
Demographic data (age and gender), heart rate,
hemoglobin level, dehydration status, stroke risk fac-
tors including hypertension, diabetes mellitus (DM),
dyslipidemia, heart disease, cigarette smoking, history
of previous stroke, and initial National Institutes of
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Health Stroke Scale (NIHSS) score on admission were
obtained for all recruited patients. Hypertension was
defined as previous diagnosis of hypertension or under
antihypertensive treatment. DM was defined as fasting
blood sugar ≥ 126 mg/dl, previous diagnosis of DM or
under hypoglycemic agent and/or insulin treatment.
Dyslipidemia was defined as fasting blood cholesterol
level ≥ 200 mg/dl, triglyceride level ≥ 150 mg/dl, LDL
cholesterol level > 130 mg/dl, HDL cholesterol level <
40 mg/dl, previous diagnosis of dyslipidemia and/or under
current lipid-lowering agent usage according to our previ-
ous study [15]. Dehydration was defined as blood urea
nitrogen to creatinine ratio over 15 (BUN/Cr > 15) and
infection was defined as concurrent infections during
admission [16]. History of heart disease included atrial
fibrillation, coronary artery disease, and/or heart failure.
Cigarette smoking was defined as daily smoking for at
least 6 months prior to stroke onset.
Cost and outcome assessment
The direct medical cost of acute stroke care was calcu-
lated from the time of admission to that of discharge, in-
cluding the expense for the personnel, imaging studies,
laboratory examinations, medications, and any interven-
tional management in the emergency department, inten-
sive care unit (ICU), and neurology ward with a similar
costing method across hospitals in Taiwan. The costs in
the rehabilitation department were not included because
stroke patients may be assigned different types of post-
acute rehabilitation programs in different institutions
with a similar length of stay according to the regulations
by NHI Administration. The cost data of this study were
retrieved by linking the SIRCHS to our hospital-based fi-
nancial system [16]. However, the medical costs in other
institution were unavailable. The long-term outcome of
each patient was assessed one year after discharge with
modified Rankin scale (mRS) by neurologists or stroke
case managers.
Statistical analysis
Data were analyzed using the Statistical Package for the
Social Sciences (SPSS) 17.0 (SPSS, Chicago, IL, USA).
Kolmogorov-Smirnov test was initially used to test the
normality. When comparing the characteristics of pa-
tients with IS and HS, the continuous data were
expressed as mean ± standard deviation, and were ana-
lyzed using an independent t test. Nominal variables
were examined by the chi-square test for parametric
data. When analyzing the IS and HS patients of different
BP subgroups, non-parametric tests were used due to
non-Gaussian distribution of these clinical data. The
continuous data were expressed as median (quartile 1,
quartile 3), and were analyzed using the Kruskal-Wallis
test. The Nemenyi-Damico-Wolfe-Dunn test was used
for post-hoc comparison. Nominal variables were also
examined by the chi-square test. Multivariate linear
regression models were further used to analyze the coef-
ficient of factors associated with admission costs. We
plotted the correlation of initial BP subgroups with
admission cost and one-year mRS score. A p value of <0.05
indicated statistical significance.
Results
Comparison between IS and HS patients
A total of 1173 IS and 282 HS patients were recruited be-
tween January 1st and December 31st in 2009. Compared
with HS patients, IS patients had older age of onset (IS vs.
HS: 67.8 ± 12.8 vs. 62.4 ± 15.4 years old, p <0.001) and
higher frequency of DM (30.3 % vs. 21.3 %, p <0.001),
infection (31.2 % vs. 18.2 %, p <0.001), elevated LDL
(20.1 % vs. 14.5 %, p =0.03) and heart disease (32.7 % vs.
17.4 %, p <0.001) (Table 1). Compared with IS patients, HS
Table 1 Characteristics of patients with IS and HS
IS HS p
n = 1173 n = 282
Demographics
Age, year 67.8 ± 12.8 62.4 ± 15.4 < 0.001*
Gender (F/M) 453/720 111/171 0.82
Stroke severity
Initial NIHSS 6.6 ± 7.1 14.7 ± 13.2 < 0.001*
Stroke outcome
Admission cost, US dollar 2305.9 ± 3351.3 3566.5 ± 4380.7 < 0.001*
Length of stay, day 14.84 ± 15.61 18.61 ± 17.88 0.001*
One-year mRS score 2.2 ± 1.9 3.4 ± 2.2 < 0.001*
Initial blood pressure
Systolic BP, mmHg 152.2 ± 23.5 157.0 ± 30.8 0.01*
Diastolic BP, mmHg 85.5 ± 13.6 88.2 ± 18.4 0.02*
Risk factor of stroke
Hypertension 737 (62.8 %) 164 (52.8 %) 0.15
Diabetes mellitus 355 (30.3 %) 60 (21.3 %) < 0.001*
Dyslipidemia
TC ≥ 200 mg/dl 305 (26.0 %) 68 (24.1 %) 0.51
LDL ≥ 130 mg/dl 236 (20.1 %) 41 (14.5 %) 0.03*
Cigarette smoking 429 (36.6 %) 88 (31.2 %) 0.09
History of previous stroke 420 (35.8 %) 78 (27.7 %) 0.17
History of heart disease 384 (32.7 %) 49 (17.4 %) < 0.001*
BUN/Cr≥ 15 421 (35.9 %) 120 (42.6 %) 0.07
Infection 214 (18.2 %) 88 (31.2 %) < 0.001*
Mean ± standard deviation is reported for continuous variables and number
(%) for categorical variables. Independent t test for continuous variables, and
chi-square test for discrete variables. IS ischemic stroke, HS hemorrhagic stroke,
NIHSS National Institutes of Health Stroke Scale, BP blood pressure, mRS modified
Rankin scale, TC total cholesterol, LDL low-density lipoprotein, BUN/Cr blood urea
nitrogen to creatinine ratio. *p value < 0.05 as statistically significant
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patients had more initial NIHSS (IS vs. HS: 6.6 ± 7.1 vs.
14.7 ± 13.2, p <0.001), initial systolic BP (IS vs. HS: 152.2
± 23.5 vs. 157.0 ± 30.8 mmHg, p =0.01) and diastolic BP
(IS vs. HS: 85.5 ± 13.6 vs. 88.2 ± 18.4 mmHg, p =0.02),
more admission costs (2305.9 ± 3351.3 vs. 3566.5 ±
4380.7 US dollars, p <0.001), and worse one-year mRS
score (2.2 ± 1.9 vs. 3.4 ± 2.2, p <0.001).
Analyses of IS patients
Table 2 shows in the IS patients, high systolic BP group had
the highest frequency of hypertension (78.6 %, p =0.01).
Low systolic BP group had the greatest frequency of infec-
tion (p =0.03), and low diastolic BP group had the least
hemoglobin level (p <0.001), the oldest age of onset
(p <0.001), and the greatest frequency of heart disease
(p =0.02) among the three BP groups. Compared with
the medium BP group, high systolic BP group was
male predominant (p =0.048) and had worse initial
NIHSS score (p =0.02). The low systolic BP group had
more infection (p =0.02), while the high diastolic BP group
had younger age of onset (p =0.003), and the low diastolic
BP group was older (p =0.004) and had more heart disease
(p =0.001) and lower hemoglobin level (p <0.001). Dehy-
dration was more common in the low systolic and dia-
stolic BP groups compared with high systolic and diastolic
BP groups (p =0.04 and 0.03, respectively). When cor-
related with systolic BP subgroups, admission cost
(Fig. 1a, p <0.001) and one-year mRS score (Fig. 1b,
p =0.03) showed a U-shape distribution. Similarly,
when correlated with diastolic BP subgroups, admis-
sion cost (Fig. 1a, p <0.01) also showed a U-shape
distribution.
The multivariate linear regression (Table 4) revealed that
admission cost was associated with initial SBP ≤ 110 mmHg
(95 % CI, 55.8 to 2338.6; p =0.04), initial NIHSS score
(95 % CI, 9.5 to 145.2; p <0.001), heart rate (95 % CI,
20.8 to 49.5; p <0.001), hemoglobin (95 % CI, −220.3
to −12.4; p <0.03), and infections during hospital stay
(95 % CI, 967.2 to 2037.3; p <0.001) after adjusting for
confounding variables including extremely high and low
initial systolic BP, extremely low initial diastolic BP, initial
NIHSS score, heart rate, hemoglobin, ratio of BUN and
creatinine, infection during admission, dyslipidemia with
total cholesterol > 200 mg/dl, smoking, and history of pre-
vious stroke, heart disease, and hypertension.
Analyses of HS patients
Table 3 shows that when compared with the medium BP
group, high systolic BP, high diastolic BP and low diastolic
BP groups had worse initial NIHSS score (p =0.01, < 0.001,
and < 0.001, respectively). Similar to IS patients, HS pa-
tients also had correlation between initial BP and
hemoglobin level (systolic BP: p =0.05; diastolic BP: p
< 0.001). When correlated with systolic BP subgroups, a
U-shape distribution was seen in one-year mRS score
(Fig. 1d, p =0.002) but not in admission cost (Fig. 1c,
Table 2 Analyses of parameters associated with systolic and diastolic BP in patients with acute IS
Systolic BP (mmHg) Diastolic BP (mmHg)
≤ 110 111 ~ 210 ≥ 211 p ≤ 70 71 ~ 110 ≥ 111 p
n = 40 n = 1119 n = 14 n = 154 n = 973 n = 46
Age, year 71.5 (56.8,76.5) 69 (59,78) 63.5 (58,77) 0.74 73 (63,80) 69 (58,77) 60.5 (53.3,70.8) < 0.001*
Gender (F/M) 15/25 429/690 9/5 0.14 67/87 368/605 18/28 0.4
Initial NIHSS score 6 (3.3,10) 4 (2,8) 7.5 (3.8,15) 0.03* 4 (2,8) 5 (2,8) 5 (2,11) 0.24
Admission cost, USD 1784
(1043.9, 4905.1)
1199.4
(844.5, 1975.7)
2315.0
(1556.7, 5395.3)
< 0.001* 1264.5
(893.1, 2556.4)
1201.1
(841.6, 1953.2)
1499.7
(1048.2, 2912.4)
0.01*
Length of stay, day 23.5 ± 23.58 14.43 ± 15.06 22.86 ± 21.73 < 0.001 15.53 ± 19.04 14.71 ± 15.1 15.24 ± 13.76 0.820
One-year mRS score 1.5 (1,5.3) 1 (1,4) 5 (1,6) 0.03* 1 (1,4) 1 (1,4) 2 (1,4) 0.41
Hypertension, % 40.0 63.4 78.6 0.01* 55.2 63.8 67.4 0.1
Diabetes mellitus, % 22.5 30.3 50.0 0.16 24.7 31.0 32.6 0.26
Heart rate, bpm 82 (71.5,89.5) 74 (65,84) 77.5 (73.5, 97.3) 0.002* 72 (62,82) 74 (65,84) 85.5 (75.8,98.2) < 0.001*
Previous stroke, % 41.7 37.5 38.5 0.88 35.7 38.0 35.0 0.81
Heart disease, % 37.5 32.7 21.4 0.54 44.8 30.7 34.8 0.02*
Hemoglobin, mg/dl 13.9 (11.7, 14.7) 13.8 (12.5, 15) 12.6 (10.6, 14.5) 0.19 13.2 (11.8,14.5) 13.8 (12.6,15.1) 14.1 (13.1,15.8) < 0.001*
BUN/Cr≥ 15, n (%) 18 (51.4) 401 (44.1) 2 (16.7) 0.11 66 (51.6) 343 (43.4) 12 (31.6) 0.07
Infection, n (%) 13 (32.5) 197 (17.6) 4 (28.6) 0.03* 32 (20.8) 171 (17.6) 11 (23.9) 0.38
Median (Q1, Q3) is reported for continuous variables and number (%) for categorical variables. BP blood pressure, IS ischemic stroke, F female, M male, USD US
dollar, One US dollars = 30 New Taiwan dollars, Previous stroke = history of previous stroke, Heart disease = history of heart disease, bpm beats per minute, NIHSS
National Institutes of Health Stroke Scale, mRS modified Rankin scale, BUN/Cr blood urea nitrogen to creatinine ratio. *p value < 0.05
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p =0.29). There was also a U-shape distribution of dia-
stolic BP subgroups with admission cost (Fig. 1c, p =0.002)
and one-year mRS score (Fig. 1d, p <0.001). The multi-
variate linear regression (Table 4) revealed that admis-
sion cost was associated with initial NIHSS score (95 %
CI, 0.02 to 78.50; p =0.05), and infection during hos-
pital stay (95 % CI, 892.84 to 2947.16; p <0.001) after
adjusting for confounding factors including extremely
low initial diastolic BP, initial NIHSS score, heart rate,
hemoglobin, infection during admission and history of
hypertension.
Discussion
Different to previous studies, our results disclosed that
in both IS and HS, patients with extremely high and
low diastolic BP had greater admission cost. Moreover,
we found that low hemoglobin level, presence of infec-
tion, severe stroke, and increased heart rate could be
the main contributors to the greater admission cost in
stroke patients with extreme BP. The modification of
these factors may help to reduce the medical expense
in the future.
The extremely low BP and admission costs
Similar to previous reports [4, 17, 18], our results also
provided evidence that extremely high and low systolic
BP were associated with poor one-year outcome in acute
IS and HS patients, demonstrating a U-shape relation-
ship between initial BP and outcome [3, 19]. Further-
more, we noted both our IS and HS patients with low
initial diastolic BP had lower hemoglobin level and
greater admission cost than patients without these con-
ditions. Hemoglobin level was inversely associated with
admission costs but not one-year mRS after adjusting
for confounding variables in IS patients. In contrast, our
HS patients with low initial diastolic BP had lower
hemoglobin and more admission cost, but the correl-
ation between hemoglobin and admission cost was insig-
nificant after adjusting for confounding factors. The
plausible explanation is that diastolic BP could be influ-
enced by blood volume [20], and anemia may cause in-
sufficient cerebral blood flow resulting in reduced
oxygen-carrying capacity [21]. The low hemoglobin level
was previously reported to lead to high cardiovascular and
non-cardiovascular mortality in patients with old age,
Fig. 1 Correlation of admission cost and one-year outcome with initial blood pressure (BP) in patients with ischemic stroke (IS) and hemorrhagic
stroke (HS). Correlation of admission cost (a) and one-year mRS (b) to initial systolic BP (SBP) and diastolic BP (DBP) in IS patients. Admission cost
(c) and (d) one-year mRS score vs. initial SBP and DBP in HS patients
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acute coronary syndrome, heart failure, or life-threatening
illness [22–25], and could cause prolonged ICU stay and
mechanical ventilator use in IS patients [23]. All these
conditions may lead to more acute care costs.
The low BP during admission could be secondary to
heart failure, coronary heart disease, dehydration, or
sepsis [5, 26]. Heart diseases including atrial fibrillation,
ischemic heart disease, and congestive heart failure may
result in reduced cardiac output, and increased length of
hospitalization and inpatient cost in patients with transi-
ent ischemic attack or who are dependent [27, 28]. It is
possible that patients with incident heart disease are frail
and prone to have worsening heart failure during admis-
sion [29, 30]. Dehydration may cause low BP, high admis-
sion infection rate, and poor clinical outcome [16].
Concurrent infection and sepsis is also known to prolong
hospital stay and increase medical cost especially in in-
sured patients, such as our patients under a universal
health insurance system [31, 32]. Our IS patients with low
diastolic BP had more heart disease and dehydration, and
those with low systolic BP had more infection (Table 2).
After adjusting for the confounding factors, our study
Table 3 Analyses of parameters associated with systolic and diastolic BP in patients with acute HS
Systolic BP (mmHg) Diastolic BP (mmHg)
≤ 110 111 ~ 210 ≥ 211 p ≤ 70 71 ~ 110 ≥ 111 p
n = 12 n = 254 n = 16 n = 47 n = 208 n = 27
Age, year 64.5 (51.5,70.8) 63 (52,75) 54.5 (48.3,64.5) 0.19 74 (58,80) 62 (52,73) 52 (45,62) < 0.001*
Gender (F/M) 5/7 101/153 5/11 0.79 24/23 80/128 7/20 0.09
Initial NIHSS score 19 (8,40) 9.5 (4,19) 24 (14,31) 0.01* 16 (8,40) 9 (3.3,16) 16 (10.3,30.8) < 0.001*
Admission cost, USD 2755.6
(2169, 7995.5)
1845.9
(1110.8, 3986.0)
1768.6
(1137.1, 6211.4)
0.29 2629.1
(1596.6, 6628.8)
1668.6
(983, 3649)
1981.2
(1488.4, 4241.6)
0.002*
Length of stay, day 13.92 ± 9.55 18.98 ± 17.97 16.19 ± 21.28 0.543 19.68 ± 16.66 18.17 ± 18.23 20.07 ± 17.69 0.790
One-year mRS score 6 (3,6) 3 (1,5) 6 (5,6) 0.002* 5 (4,6) 3 (1,5) 5 (2,6) < 0.001*
Hypertension, % 41.7 60.6 31.3 0.03* 48.9 61.1 51.9 0.25
Diabetes mellitus, % 33.3 20.5 25.0 0.53 34.0 18.8 18.5 0.54
Heart rate, bpm 83 (77.5,92) 76 (66,86) 88.5 (77.3, 96.3) 0.01* 77 (65.5,87.5) 76 (67,87) 83 (73,93.5) 0.23
Previous stroke, % 30.0 32.9 37.5 0.94 41.0 31.3 31.8 0.5
Heart disease, % 25.0 16.9 18.8 0.76 21.3 17.3 11.1 0.54
Hemoglobin, mg/dl 11.8 (10.7,13.6) 13.9 (12,15) 14.0 (12.6,15.6) 0.05* 12.7 (11.0,14.0) `13.9 (12.2,15) 15.2 (13.4,16.2) < 0.001*
BUN/Cr≥ 15, n (%) 6 (54.6) 111 (51.9) 3 (25.0) 0.19 25 (58.1) 85 (49.7) 10 (43.5) 0.47
Infection, n (%) 5 (41.7) 77 (30.3) 6 (37.5) 0.62 19 (40.4) 61 (29.3) 8 (29.6) 0.33
Median (Q1, Q3) is reported for continuous variables and number (%) for categorical variables. BP blood pressure, HS hemorrhagic stroke, F female, M male, USD
US dollar, One US dollars = 30 New Taiwan dollars, Previous stroke = history of previous stroke, Heart disease = history of heart disease, bpm beats per minute,
NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin scale, BUN/Cr blood urea nitrogen to creatinine ratio. *p value < 0.05
Table 4 Multivariate linear regression analyses of factors associated with admission costs in stroke patients
IS HS
Admission cost,
USD
Factors Linear regression
coefficient
95 % CI P
value
Factors Linear regression
coefficient
95 % CI P
value
Initial NIHSS
score
112.4 79.5 to
145.2
<0.001 Initial NIHSS
score
39.26 0.02 to 78.50 0.051
Heart rate,
bpm
35.1 20.8 to 49.5 <0.001 Infection 1920.00 892.84 to
2947.16
<0.001
Hemoglobin,
mg/dl
−116.4 −220.3 to
−12.4
0.028
Infection 1502.3 967.2 to
2037.3
<0.001
Low SBP
(≤110 mmHg)
1197.2 55.8 to
2338.6
0.040
High SBP
(≥ 211 mmHg)
1763.8 −8.4 to
2526.0
0.051
IS ischemic stroke, HS hemorrhagic stroke, USD US dollar, bpm beats per minute, NIHSS National Institutes of Health Stroke Scale, SBP systolic blood pressure
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provided evidence that infection could be a major con-
tributor to increased admission costs in patients during
the acute treatment of stroke (Table 4).
The extremely high BP to admission costs
Early intensive BP control in HS was reported to im-
prove outcomes in INTERACT 2 and ATACH-II trials
[33, 34]. Our observational study was consistent with
the results demonstrating a linear association between
physical dysfunction and baseline systolic BP in INTER-
ACT 2 trial [35]. The elevated BP during acute stroke
could be related to previous history of hypertension,
increased intracranial pressure, stress of hospitalization,
or autonomic system activation [26, 36, 37]. The Cush-
ing reflex (raised BP, reduced heart rate, and irregular
breathing) which is a CNS homeostatic response to in-
creased intracranial pressure [38] could occur in intrace-
rebral hemorrhage or large ischemic stroke. Both our IS
and HS patients with extremely high BP had increased
HR instead of bradycardia. It is possible that acute
stroke may induce sympathetic activation or develop-
ment of Cushing reflex which contributes to extremely
high BP in the beginning [38]. It is known that high ad-
mission blood sugar is associated with poor outcome
[39], and our study showed the DM was more common
in IS patients with high BP (p =0.05) than low BP.
Initial stroke severity and admission costs
Our results suggested that initial stroke severity is the
important contributor to admission cost in IS and HS
patients with initial extreme BP (Table 4). Besides, our
IS patients with extreme systolic BP and HS patients
with extreme diastolic BP had more admission cost and
worse one-year outcome especially when associated with
worse initial NIHSS score. In previous studies, it has
been shown that HS patients with worse initial stroke
severity may have longer hospital stay and more post-
stroke infection [13, 40]. It is also reported that high
baseline NIHSS score is likely to be associated with large
infarct volume in patients with anterior circulation
stroke and can predict progression of neurological deficit
and poor 3-month clinical outcome in patients with pos-
terior circulation stroke [41, 42].
Limitations
First, our study only included the direct medical costs of
acute care but did not collect the costs up to 12 months
to correlate with the long-term outcome. Second, since
this is a single center study, the generalizability may be
limited. However, Chang et al. reported that similar to
previous results, the initial stroke severity may predict
costs of acute care in Taiwanese IS patients [2]. Since
Taiwan has one-payer insurance system that covers more
than 99 % of the population, the results of our study
could be well generalized in Taiwan. However, the
generalizability beyond Taiwan may need further valid-
ation because of the diversity of medical insurance sys-
tem among different countries. Third, we used the initial
BP but not the 24-h ambulatory BP as the predictor.
The initial BP may be influenced by many factors and is
sometimes unreliable. Fourth, we did not consider im-
aging findings such as infarction/hematoma location and
volume, as infarction/hematoma expansion with brain
stem destruction may result in low initial BP and is asso-
ciated with high admission cost and poor stroke out-
come. Fifth, we did not make a distinction between
infection on admission and in-hospital infection. Finally,
the small sample size of our patients with extreme BP
may also have limited power to show the significance.
Nevertheless, our study has provided evidence that fu-
ture studies should be undertaken to examine whether
the correction of these factors may help reduce the med-
ical expense related to acute hospital care and improve
the long-term outcome.
Conclusions
A U-shape relationship can be seen between initial sys-
tolic/diastolic BP and admission cost as well as one-year
mRS score in both IS and HS patients. Infection is associ-
ated with high admission costs in both IS and HS patients.
Severe stroke, increased heart rate, and low hemoglobin
and systolic BP on admission significantly increased total
admission costs and patients with these conditions should
be carefully monitored to avoid complications.
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